Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON39461Active, not recruiting
Open-label, single-arm trial of haloperidol in delirium and Dementia, sponsored by Jeroen Bosch Hospital. Primary endpoints: Haloperidol concentration in serum, Haloperidol concentration in cerebrospinal fluid and 2 more. Started Jan 2012; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON39461.